The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions

Coronary Arterial Disease (CAD)Angina (Stable)

Interventions

DRUG

Glycerin trinitrate (GTN)

2 sublingual puffs for a total dose of 800 µg

DRUG

Saline (NaCl 0,9 %) (placebo)

2 puffs of sublingual saline

Trial Locations (1)

OLV Cardiovascular Center Aalst, Aalst

All Listed Sponsors

lead

VZW Cardiovascular Research Center Aalst

OTHER

NCT06823843 - The Effect of Sublingual Nitroglycerin on Absolute Coronary Blood Flow | Biotech Hunter | Biotech Hunter